WASHINGTON, DC - JULY 20: Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, testifies at a Senate Health, Education, Labor, and Pensions Committee hearing at the Dirksen Senate Office Building on July 20, 2021 in Washington, DC. The committee will hear testimony about the Biden administration's ongoing plans to deal with the COVID-19 pandemic and Delta variant. (Photo by Stefani Reynolds-Pool/Getty Images)

WASHINGTON, D.C. – JULY 20: Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, testifies at a Senate Health, Education, Labor, and Pensions Committee hearing at the Dirksen Senate Office Building on July 20, 2021 in Washington, D.C. (Photo by Stefani Reynolds-Pool/Getty Images)

OAN Newsroom
UPDATED 4:48 PM PT – Sunday, October 17, 2021

Health officials say the Johnson and Johnson vaccine should have originally been two doses. Despite data showing the J&J vaccine wasn’t as effective as the others, like Moderna and Pfizer, White House Chief Medical Adviser Anthony Fauci said recipients should “feel good about the booster recommendation.”

During an interview Sunday, the health expert said recipients of the single-dose J&J vaccine shouldn’t be concerned about the shot’s lower efficacy now that boosters have been recommended. The Food and Drug Administration (FDA) advisory panel unanimously decided to approve the J&J booster on Friday and are advising people to get it sooner rather than later.

“Everyone who’ve received that first dose of J&J who are 18 and older should receive it,” said Fauci. “So, I think that’s a very good thing. And I think it’s very favorable for those who have received the J&J vaccine. I don’t see that as a problem at all.”

The J&J booster is now available for everyone above the age of 18, but Pfizer and Moderna boosters are only being offered to those 65 and older, and those who are at higher risk, raising concerns about the key differences. Interestingly enough, health officials also confirmed boosting with a different shot than one’s original vaccine seems to be safe and effective.

Although it hasn’t been peer reviewed yet, data revealed J&J recipients who received a Pfizer or Moderna booster had higher antibody levels, making people question which one they should take. Fauci further added that the other vaccine boosters found to be more effective was discovered through “laboratory” data and that boosting the J&J first dose with a J&J second dose is based on “clinical” data, even though he has claimed they’re reflective of each other.

Future plans include the FDA looking into all types of data in order to make determinations on what they’ll authorize. These decisions won’t be made until the Centers for Disease Control and Prevention (CDC) observes data from Israel, which is about a month ahead of the U.S. in its vaccine distribution.

In the meantime, Fauci said the FDA is on track to approve the Pfizer vaccine for children ages 5-to-11 in early November and health experts have insisted those who haven’t yet received a booster go get one immediately.

MORE NEWS: Migrants Remain Stuck On Caribbean Coast

Laat een bericht achter! Doe mee, wat vind u (jij) hiervan?

HNMDA UPDATE'S
!!! Blijf op de hoogte

! Meld je aan


.Meld je aan via mail

OF op telegram https://t.me/HNMDA_ALL


- S'morgens & S'avonds 1 nieuwsbrief met de nieuwste berichten
- Weekelijkse nieuwsbrief met alle headlines
- Soms een (verkeerd/ongewenst/test) mailtje, daar werken we aan...


...Anders hoor je het niet